Assessment Of Quality Of Life And Modulating The Diet And Drug Interventions A Paradigm Shift


Affiliations

  • Conquer Diabetes, Mumbai, India

Abstract

Objectives: We evaluated Quality of Life(QOL) parameter for the care of people with diabetes. Method: We conducted a prospective study and evaluated QOL using QOL Instrument for Indian Diabetes (QOLID) patient's questionnaire, comprising 8 domains, 34 items, in 369 consecutive patients as a single point assessment tool. We calculated percentage score for each domain and mean value formed basis for calculation of weighted score. Descriptive statistics was used for analysis. Results: 369 patients were administered the QOLID (173 males, 196 females). Mean age was 59 years (range 19- 81, SD ± 11,95% Cl 58 to 60). Mean HbAlc was 8.1 % (range 5.3-16, SD ± 1.6,95% Cl 7.9 to 8.3). Notably, 278 patients had HbAlc > 7. 26%. 91 patients had HbAlc <7. Mean duration of diabetes was 11 years (range 0.2 -40, SD ± 7.8,95% Cl 10 to 12). Mean duration of follow up since first visit was 25 months (range 1-44, SD± 12,95% Cl 24 to 27). Mean number of visits were 7.7 (range 1-25, SD± 3.7,95% Cl 7.4 to 8.1). 89.7 % (n=331) were exclusively on OHA, 26 patients were both on OHA and insulin and only 12 patients were exclusively on lifestyle modification.

Keywords

No Keywords

Full Text:

References

Skevington SM, Lotfy M, O'Connell KA. The World Health Organization's WHOQOL-BREF quality of life assessment:

psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research 2004; 13:299-310.26. Rubin RR, Peyrot M.

. Quality of life and diabetes. Diabetes/Metaholism Research and Reviews 1999; 15:205-18.27.

Testa MA. Quality-of-life assessment in diabetes research: interpretin g the magnitude and meaning of treatment effects. Diabetes Spectrum 2000; 13:29.28.

American Diabetes Association. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). UK Prospective Diabetes Study Group. Diabetes Care 1999; 22:112536.

Glycemic Pentad Forum. Glycemic Pentad. Journal of The Association of Physicians of India 2017:65

Ceriello A. The glucose triad and its role in comprehensive glycemic control: current status, future management. International Journal of Clinical Practice 2010; 64:1705-11

American Diabetes Association. Promoting health and reducing disparities in populations. Standards of Medical Care in Diabetes 2017. Diabetes Care 2017; 40.

Monnier L, Lapinsk i H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients. Diabetes Care 2003; 26:881-5

Jitender Nagpal. The Development of 'Quality of Life Instrument for Indian Diabetes Patients (QOLID): A Validation and Reliability Study in Middle and Higher Income Groups.JAPI;2010:58

International Diabetes Federation. Clinical Guidelines Task Force Global Guideline for Type 2 Diabetes, 2012, Available at http://www.idf.org/sites/default/files/IDFGuideline-for-Type-2-Diabetes.pdf


Refbacks

  • There are currently no refbacks.